Welcome to NTK Institute

All alendronate News

01/14/2015	Treatment of primary osteoporosis in men (Clin Interv Aging)
12/31/2014	Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover (Aging Clin Exp Res)
12/16/2014	Current and future treatments of osteoporosis in men (Best Pract Res Clin Endocrinol Metab)
12/04/2014	Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference (J Endocrinol Invest)
11/19/2014	Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures (Clin Rheumatol)
10/30/2014	Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches (Curr Osteoporos Rep)
10/21/2014	Bisphosphonate-Induced Cutaneous Adverse Events: The Difficulty of Assessing Imputability through Patch Testing (Dermatology)
10/20/2014	Is There Enough Evidence to Use Bisphosphonates in HIV-Infected Patients? A Systematic Review and Meta-analysis (AIDS Rev)
08/19/2014	Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer: Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid (JAMA Intern Med)
07/07/2014	The potential impact of new effervescent alendronate formulation on compliance and persistence in osteoporosis treatment (Aging Clin Exp Res)
05/30/2014	Incidence and Risk of Venous Thromboembolism Among Taiwan Osteoporotic Fracture Population under Osteoporosis Pharmacological Treatments (J Clin Endocrinol Metab)
05/13/2014	Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy: The FLEX Study (JAMA Intern Med)
05/06/2014	Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials (J Bone Miner Metab)
04/29/2014	Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis (Osteoporos Int)
04/17/2014	The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate (Bone)
04/11/2014	Fracture Risk Reduction with Denosumab in Japanese Postmenopausal Women and Men with Osteoporosis: Denosumab fracture Intervention RandomizEd placebo Controlled Trial (DIRECT) (J Clin Endocrinol Metab)
04/08/2014	Established and forthcoming drugs for the treatment of osteoporosis (Curr Opin Rheumatol)
04/03/2014	Use of strontium ranelate and risk of acute coronary syndrome: cohort study (Ann Rheum Dis)
04/01/2014	Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis (J Clin Pharm Ther)
03/27/2014	External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review (Osteoporos Int)
03/27/2014	Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy (Rheumatol Int)
03/26/2014	The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab (Gynecol Endocrinol)
03/24/2014	Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis (Menopause)
03/20/2014	Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate (Clin Rheumatol)
03/10/2014	Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss (Osteoporos Int)
03/10/2014	Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study (Osteoporos Int)
03/10/2014	Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis (Osteoporos Int)
03/07/2014	Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population (Osteoporos Int)
02/18/2014	A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment (Bone)
01/10/2014	Differing Effects of Denosumab and Alendronate on Cortical and Trabecular Bone (Bone)

1 2 3 Next